FDA Says J & J Halted Doribax Trial Due to Safety Issues
Johnson & Johnson shut down a clinical trial of its antibiotic Doribax for a type of pneumonia after patients taking the drug had higher rates of death and a lower cure rate than those who got an alternative medicine, U.S. …